Australia seems poised to gain access to potentially transformative medication for excess weight: Retatrutide. This dual molecule – acting on both GLP-1 and GIP receptors – demonstrates significant efficacy in global trials, pointing to meaningful decreases in body fat. While regulatory clearance is pending with the Therapeutic Goods Administra… Read More